Status:
COMPLETED
A Single-center Study to Assess Peak Inspiratory Flow (PIF) in Different Stages' COPD Patients by Using the In-check Method.
Lead Sponsor:
Elpen Pharmaceutical Co. Inc.
Conditions:
Pulmonary Disease
Eligibility:
All Genders
50-90 years
Brief Summary
Peak Inspiratory Flow Rate (PIFR) is defined by the fastest flow rate noted during the inspiratory cycle. Inhaled medication plays an important role in the treatment of chronic obstructive pulmonary ...
Detailed Description
This study will assess the inspiratory flow rates at high levels of resistance in different stages of COPD patients. PIF will be measured by in-check method. Commonly used for Asthma patients, the In...
Eligibility Criteria
Inclusion
- COPD patients (Global Initiative of Chronic Lung Disease (GOLD) definition
- COPD stage II, III, IV
- Patients who are followed in Outpatients' Unit
- Patients \>50 years of age
- Patients who accept PIF to be measured using the In-Check Inhaler
- Patients who have signed the Informed Consent
- Patients who will comply with study demands and procedures
Exclusion
- COPD stage I patients
- Patients who are hospitalized
- Patients \<50 years of age
- Patients who do not accept PIF to be measured using the In-Check Inhaler
- Patients who have not signed the Informed Consent
- Patients who face problems in order to comply with study demands and procedures
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01855659
Start Date
June 1 2013
End Date
November 1 2013
Last Update
December 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
7th Pulmonary Dept, Athens Chest Hospital
Athens, Mesogion Ave. 152, Greece, Athens 11527